TAUC3BIO CORPORATION is a privately-held biopharmaceutical company focused on the development of innovative high precision immunotherapies for the treatment of tauopathies such as Alzheimer’s disease (AD) and Progressive Supranuclear Palsy (PSP). Its patented platform relates to the development of monoclonal antibodies (mAbs) targeting neurotoxictau protein fragments, especially tauC3, with mAbs that do not bind to full-length tau (FLT).It was founded in 2019 and headquartered in Holborn, Camden.

Biotechnology

Pharmaceutical

TauC3 Biologics Limited

TauC3 Biologics Limited's headquarters in Holborn, United Kingdom

TauC3 Biologics Limited

Org chart

Board & advisors

Teams

Offices

Similar companies